Literature DB >> 23679304

Decreased expression of LKB1 correlates with poor prognosis in hepatocellular carcinoma patients undergoing hepatectomy.

Yue-Han Huang1, Zhen-Kun Chen, Ka-Te Huang, Peng Li, Bin He, Xu Guo, Jun-Qiao Zhong, Qi-Yu Zhang, Hong-Qi Shi, Qi-Tong Song, Zheng-Ping Yu, Yun-Feng Shan.   

Abstract

AIM: To study any correlation of LKB1 expression with prognosis in hepatocellular carcinoma (HCC) cases.
METHODS: A total of 70 HCC patients and 20 primary intrahepatic stone patients in the first affiliated hospital of Wenzhou Medical College were enrolled in this study. LKB1 expression was detected by immunohistochemistry. Patients were followed-up and prognostic factors were evaluated. RESULT: LKB1 expression was decreased in the HCC samples. Loss of LKB1 expression in HCC was significantly related to histologic grade (P=0.010), vascular invasion (P=0.025) and TMN stage (P=0.011). Patients showing negative LKB1 expression had a significantly shorter disease-free and overall survival than those with positive expression (P = 0.001, P=0.000, respectively). Multivariate Cox regression analysis indicated that LKB1 expression level was an independent factor of survival (P = 0.033).
CONCLUSION: HCC patients with decreased expression LKB1 have a poor prognosis. The loss of LKB1 expression is correlated with a lower survival rate.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23679304     DOI: 10.7314/apjcp.2013.14.3.1985

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  13 in total

1.  Targeted sequencing of cancer-associated genes in hepatocellular carcinoma using next-generation sequencing.

Authors:  Asahiro Morishita; Hisakazu Iwama; Shintaro Fujihara; Miwako Watanabe; Koji Fujita; Tomoko Tadokoro; Kyoko Ohura; Taiga Chiyo; Teppei Sakamoto; Shima Mimura; Takako Nomura; Joji Tani; Hirohito Yoneyama; Keiichi Okano; Yasuyuki Suzuki; Takashi Himoto; Tsutomu Masaki
Journal:  Oncol Lett       Date:  2017-11-02       Impact factor: 2.967

2.  LKB1 loss promotes endometrial cancer progression via CCL2-dependent macrophage recruitment.

Authors:  Christopher G Peña; Yuji Nakada; Hatice D Saatcioglu; Gina M Aloisio; Ileana Cuevas; Song Zhang; David S Miller; Jayanthi S Lea; Kwok-Kin Wong; Ralph J DeBerardinis; Antonio L Amelio; Rolf A Brekken; Diego H Castrillon
Journal:  J Clin Invest       Date:  2015-09-28       Impact factor: 14.808

Review 3.  Prognostic biomarkers for prediction of recurrence of hepatocellular carcinoma: current status and future prospects.

Authors:  Seow Chong Lee; Hwee Tong Tan; Maxey Ching Ming Chung
Journal:  World J Gastroenterol       Date:  2014-03-28       Impact factor: 5.742

4.  Sodium butyrate induces autophagy in colorectal cancer cells through LKB1/AMPK signaling.

Authors:  Shunli Luo; Ziyin Li; Lianzhi Mao; Siqiang Chen; Suxia Sun
Journal:  J Physiol Biochem       Date:  2018-10-25       Impact factor: 4.158

Review 5.  Targeting AMPK for cancer prevention and treatment.

Authors:  Weidong Li; Shakir M Saud; Matthew R Young; Guohong Chen; Baojin Hua
Journal:  Oncotarget       Date:  2015-04-10

6.  Expression of Phosphorylated AMP-Activated Protein Kinase Predicts Response to Transarterial Chemoembolization in Postoperative Cases of Hepatocellular Carcinoma.

Authors:  Long-Yi Zheng; Lu Wu; Jin Lu; Da-Jin Zou; Qin Huang
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

7.  Decreased expression of LKB1 predicts poor prognosis in pancreatic neuroendocrine tumor patients undergoing curative resection.

Authors:  Dezhi Li; Yu Zhou; Yanhui Liu; Ye Lin; Min Yu; Xin Lu; Bowen Huang; Zhonghai Sun; Zhixiang Jian; Baohua Hou
Journal:  Onco Targets Ther       Date:  2018-03-06       Impact factor: 4.147

8.  Downregulation of LKB1 promotes tumor progression and predicts unfavorable prognosis in patients with glioma.

Authors:  Jiehao Huang; Hongwu Chen; Quantang Wei; Ziheng Zhang; Zhiwei Zhong; Yimin Xu
Journal:  Oncol Lett       Date:  2017-01-23       Impact factor: 2.967

9.  The Prognostic Value of Decreased LKB1 in Solid Tumors: A Meta-Analysis.

Authors:  Jian Xiao; Yong Zou; Xi Chen; Ying Gao; Mingxuan Xie; Xiaoxiao Lu; Wei Li; Bixiu He; Shuya He; Shaojin You; Qiong Chen
Journal:  PLoS One       Date:  2016-04-01       Impact factor: 3.240

10.  Upregulation of liver kinase B1 predicts poor prognosis in hepatocellular carcinoma.

Authors:  Xiaolong Tan; Zhibin Liao; Huifang Liang; Xiaoping Chen; Bixiang Zhang; Liang Chu
Journal:  Int J Oncol       Date:  2018-09-07       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.